TR201909836T4 - Sitisinin katı farmasötik bileşimi ve bunun hazırlanması için proses. - Google Patents

Sitisinin katı farmasötik bileşimi ve bunun hazırlanması için proses. Download PDF

Info

Publication number
TR201909836T4
TR201909836T4 TR2019/09836T TR201909836T TR201909836T4 TR 201909836 T4 TR201909836 T4 TR 201909836T4 TR 2019/09836 T TR2019/09836 T TR 2019/09836T TR 201909836 T TR201909836 T TR 201909836T TR 201909836 T4 TR201909836 T4 TR 201909836T4
Authority
TR
Turkey
Prior art keywords
pharmaceutical composition
solid pharmaceutical
citrine
preparation
cyticin
Prior art date
Application number
TR2019/09836T
Other languages
English (en)
Inventor
Berdzinska Katarzyna
Kieronska Hanna
Milewski Marek
Nawrocka Malgorzata
Klepczynska Marta
Original Assignee
Bonteque Consulting Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54011933&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR201909836(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bonteque Consulting Ltd filed Critical Bonteque Consulting Ltd
Publication of TR201909836T4 publication Critical patent/TR201909836T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Buluş, etken bir madde olarak sitisin içeren katı bir farmasötik bileşim ile ilgilidir. Bileşim, ağırlıkça %20 ila %75 arasında mikrokristalin selüloz, kayganlaştırıcı ve mannitol, koloidal silikon dioksit, kalsiyum hidrojen fosfat içeren bir gruptan seçilen farmasötik olarak kabul edilebilir en az bir yardımcı madde içermesi ile karakterize edilir, burada sitisin partiküllerinin en az %60'ı 10 pm ila 200 pm arasında boyuta sahiptir.
TR2019/09836T 2014-06-18 2015-06-17 Sitisinin katı farmasötik bileşimi ve bunun hazırlanması için proses. TR201909836T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL408608A PL408608A1 (pl) 2014-06-18 2014-06-18 Trwała stała kompozycja farmaceutyczna cytyzyny oraz sposób jej wytwarzania

Publications (1)

Publication Number Publication Date
TR201909836T4 true TR201909836T4 (tr) 2019-07-22

Family

ID=54011933

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/09836T TR201909836T4 (tr) 2014-06-18 2015-06-17 Sitisinin katı farmasötik bileşimi ve bunun hazırlanması için proses.

Country Status (12)

Country Link
EP (1) EP2957280B1 (tr)
CY (1) CY1121986T1 (tr)
DK (1) DK2957280T3 (tr)
ES (1) ES2732711T3 (tr)
HR (1) HRP20191217T1 (tr)
HU (1) HUE044804T2 (tr)
LT (1) LT2957280T (tr)
PL (2) PL408608A1 (tr)
PT (1) PT2957280T (tr)
RS (1) RS58983B1 (tr)
SI (1) SI2957280T1 (tr)
TR (1) TR201909836T4 (tr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201602145D0 (en) 2016-02-05 2016-03-23 Achieve Pharma Uk Ltd Salt
EP3598968A1 (en) 2018-07-23 2020-01-29 Adamed Pharma S.A. Solid pharmaceutical cytisine composition
BG67408B1 (bg) * 2019-04-12 2022-01-17 Софарма Ад Перорален лекарствен състав с растителен алкалоид, за лечение на зависимости
CN115487158A (zh) * 2021-06-18 2022-12-20 北京万全德众医药生物技术有限公司 一种金雀花碱片剂及其制备方法
WO2025128723A1 (en) * 2023-12-12 2025-06-19 Achieve Life Sciences, Inc. Cytisine formulations
US20250186416A1 (en) * 2023-12-12 2025-06-12 Achieve Life Sciences, Inc. Smoking cessation compounds having reduced nitrosamines and associated methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59500217A (ja) 1982-02-22 1984-02-16 ベロルススキ−　ナウチノ−　イスレドワ−チエルスキ−　サニタルノ−　ギギエニチエスキ−　インスチツ−ト 抗ニコチン効果を有する製剤およびその製造法
CA2233632C (en) 1996-05-20 2002-07-16 Andrej Zinovyevich Vitik Phosphorus containing cythesine derivatives
BG65536B1 (bg) 2004-04-16 2008-11-28 "Софарма" Ад Лекарствена форма, съдържаща цитизин
EP2233134A1 (en) * 2009-03-27 2010-09-29 McNeil AB Multi-portion intra-oral dosage form with organoleptic properties
PL220354B1 (pl) 2012-11-19 2015-10-30 Aflofarm Fabryka Leków Spółka Z Ograniczoną Odpowiedzialnością Stała postać dawkowania zawierająca zmikronizowaną cytyzynę oraz sposób jej otrzymywania

Also Published As

Publication number Publication date
EP2957280B1 (en) 2019-04-17
EP2957280A1 (en) 2015-12-23
SI2957280T1 (sl) 2019-08-30
PL2957280T3 (pl) 2019-09-30
CY1121986T1 (el) 2020-10-14
PT2957280T (pt) 2019-07-23
LT2957280T (lt) 2019-07-25
PL408608A1 (pl) 2015-12-21
RS58983B1 (sr) 2019-08-30
DK2957280T3 (da) 2019-07-22
ES2732711T3 (es) 2019-11-25
HRP20191217T1 (hr) 2019-10-18
HUE044804T2 (hu) 2019-11-28

Similar Documents

Publication Publication Date Title
SG10201804817TA (en) Delayed release compositions of linaclotide
SG10201810985XA (en) Tofacitinib oral sustained release dosage forms
MY196319A (en) Polycyclic TLR7/8 Antagonists and use Thereof in the Treatment of Immune Disorders
EA201690962A1 (ru) Составы
TW201613880A (en) Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole
PH12016502103A1 (en) Novel disubstituted 1,2, 4-triazine compound
EP4414376A3 (en) Novel depsipeptide and uses thereof
CY1121986T1 (el) Στερεη φαρμακευτικη συνθεση κυtισινης και διαδικασια για την παρασκευη της
EP4327880A3 (en) Solid state form of ribociclib succinate
EA201791009A1 (ru) Композиции, содержащие циклоспорин
MD4563B1 (ro) Produs de comicronizare cu conţinut de acetat de ulipristal
MX2016001422A (es) Composicion farmaceutica de fingolimod.
TW201129386A (en) Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
MX366829B (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
PH12016502544B1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
EA201892842A1 (ru) Фармацевтические композиции, включающие сафинамид
WO2016197042A8 (en) Modified or targeted release formulations of linaclotide
PH12019500024A1 (en) Pharmaceutical compositions
MX370184B (es) Composición farmacéutica que comprende fingolimod.
IN2013MU03428A (tr)
WO2014122671A3 (en) Solid oral compositions of saxagliptin
IN2014DN07898A (tr)
EA202091127A1 (ru) Фармацевтические композиции, включающие сафинамид
EA202090397A1 (ru) Фторопиперидиновые соединения в качестве чистых антагонистов 5-ht-рецептора
TN2016000561A1 (en) Stabilized desmopressin